Literature DB >> 3658524

Gastroesophageal reflux and unexplained chronic respiratory disease in infants and children.

A Malfroot1, Y Vandenplas, M Verlinden, A Piepsz, I Dab.   

Abstract

Thirty-eight children, aged from a few weeks to 7 years, with severe chronic pulmonary disease and without gastrointestinal symptoms, were investigated for gastroesophageal reflux (GER), using prolonged pH probe monitoring and gastroesophageal scintiscanning. All treatments were discontinued before testing. GER was found in 24 patients (63%) (group I) and it was not observed in 14 patients (group II). All patients of group I received antireflux treatment, consisting of cisapride; in 22 of 24 patients, GER was controlled, as indicated by improvement of either pH monitoring or scintiscanning, or both. Eighteen of these 22 (82%) had remission of their pulmonary disease, and only two patients of group II (14%) had spontaneous remission of the respiratory symptoms. We concluded that GER was probably the cause of the respiratory disease in 63% of our patients, since treatment of GER was followed by disappearance of the respiratory complaints in most of them. The combination of gastroesophageal scintiscanning and pH probe study improved the diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3658524     DOI: 10.1002/ppul.1950030403

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  14 in total

1.  Varicella: to vaccinate or not to vaccinate?

Authors:  A Gershon
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 2.  Paediatric nuclear medicine.

Authors:  A Piepsz; I Gordon; K Hahn
Journal:  Eur J Nucl Med       Date:  1991

Review 3.  Gastro-oesophageal reflux and the lung.

Authors:  H Simpson; F Hampton
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

4.  Population pharmacokinetics of enterally administered cisapride in young infants with gastro-oesophageal reflux disease.

Authors:  Y Preechagoon; B Charles; V Piotrovskij; T Donovan; A Van Peer
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

5.  Diagnosis and treatment of gastroesophageal reflux disease in infants and children.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

Review 6.  The interpretation of oesophageal pH monitoring data.

Authors:  Y Vandenplas; H Loeb
Journal:  Eur J Pediatr       Date:  1990-06       Impact factor: 3.183

7.  The risks and benefits of cisapride in premature neonates, infants, and children.

Authors:  A Lander; A Desai
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 8.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 9.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

10.  New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.

Authors:  A Malfroot; I Dab
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.